Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMVV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,225
Award facts
- Contract value 100% obligated
- $49,224.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $49,224.90 by the Defense Logistics Agency on August 19, 2025. The delivery order covers Keytruda 100 mg/4 mL vials for delivery to Park Ridge, Illinois, with an ultimate completion date of September 10, 2025. This award was made without a set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace. Keytruda is a leading immunotherapy medication used primarily in oncology treatments, reflecting DMS Pharmaceutical Group's established role in supplying specialized pharmaceutical products to Department of Defense healthcare facilities.
This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group's consistent success in securing such delivery orders demonstrates its established position as a critical supplier within the federal pharmaceutical supply chain for Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DB25FNMVV?
SPE2DB25FNMVV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FNMVV worth?
The government has obligated $49,225 on SPE2DB25FNMVV.
Is contract SPE2DB25FNMVV an order under another contract?
Yes. SPE2DB25FNMVV is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMVV competed?
The extent of competition for SPE2DB25FNMVV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award